Working… Menu
Trial record 1 of 1 for:    D9108C00001
Previous Study | Return to List | Next Study

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC (COAST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03822351
Recruitment Status : Recruiting
First Posted : January 30, 2019
Last Update Posted : November 22, 2019
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 23, 2023
Estimated Study Completion Date : October 23, 2023